Arcutis Biotherapeutics (ARQT) Shares Outstanding (2020 - 2025)
Arcutis Biotherapeutics has reported Shares Outstanding over the past 6 years, most recently at $123.3 million for Q4 2025.
- Quarterly results put Shares Outstanding at $123.3 million for Q4 2025, up 4.65% from a year ago — trailing twelve months through Dec 2025 was $123.3 million (up 4.65% YoY), and the annual figure for FY2025 was $123.3 million, up 4.65%.
- Shares Outstanding for Q4 2025 was $123.3 million at Arcutis Biotherapeutics, up from $120.3 million in the prior quarter.
- Over the last five years, Shares Outstanding for ARQT hit a ceiling of $123.3 million in Q4 2025 and a floor of $49.9 million in Q1 2021.
- Median Shares Outstanding over the past 5 years was $61.7 million (2023), compared with a mean of $82.8 million.
- Biggest five-year swings in Shares Outstanding: increased 1.56% in 2023 and later skyrocketed 89.14% in 2024.
- Arcutis Biotherapeutics' Shares Outstanding stood at $50.3 million in 2021, then rose by 21.45% to $61.0 million in 2022, then surged by 58.57% to $96.8 million in 2023, then increased by 21.76% to $117.8 million in 2024, then increased by 4.65% to $123.3 million in 2025.
- The last three reported values for Shares Outstanding were $123.3 million (Q4 2025), $120.3 million (Q3 2025), and $119.8 million (Q2 2025) per Business Quant data.